Caricamento...
Enzalutamide in chemo-naïve castration-resistant prostate cancer: effective for most but not for all
Continued research in the treatment of castration-resistant prostate cancer (CRPC) has allowed for a clearer understanding of this disease entity and further treatment advances. In a study recently published by Beer et al.1 in the New England Journal of Medicine, another advance to treatment was dem...
Salvato in:
| Pubblicato in: | Asian J Androl |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Medknow Publications & Media Pvt Ltd
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4236319/ https://ncbi.nlm.nih.gov/pubmed/25155108 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.137680 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|